Precision Clinical and Genetic Tools for Brain Health in Hemorrhagic Stroke
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Hemorrhagic Stroke
- Sponsor
- Massachusetts General Hospital
- Enrollment
- 340
- Locations
- 1
- Primary Endpoint
- Proportion of patients with LDL measurements
- Status
- Completed
- Last Updated
- 11 months ago
Overview
Brief Summary
The overall goal of this study is to increase health care provider awareness for common risk factors and comorbidities in patients with hemorrhagic stroke that are related to impaired brain health, to ultimately improve patients management and associated outcomes. The specific objective is to test the performance and effectiveness of a custom electronic health record (EHR)-based notification module at time of index hospitalization and at follow-up for hemorrhagic stroke survivors, before disparities in access to outpatient care may limit opportunities to intervene.
The investigators hypothesize that notification of health care providers through the EHR will increase measurements of low-density lipoprotein (LDL) and glycated hemoglogbin A1c (HbA1c) and increase evaluation and management rates for obstructive sleep apnea and hearing impairment.
Investigators
Christopher D. Anderson, MD, MMSc
Division Chief of Stroke and Cerebrovascular Disease
Brigham and Women's Hospital
Eligibility Criteria
Inclusion Criteria
- •Patients aged 18 years or older
- •Presenting with a primary diagnosis of hemorrhagic stroke admitted to Massachusetts General Hospital inpatient stroke service
Exclusion Criteria
- •Patients not meeting above inclusion criteria
- •Patients presenting with subdural or epidural hematoma
Outcomes
Primary Outcomes
Proportion of patients with LDL measurements
Time Frame: 12 months
Proportion of patients with any LDL measurements in the 12-months period surrounding acute hemorrhagic stroke (6-months before and 6-months follow-up following discharge). LDL measurements will be ascertained based on electronic health record documentation.
Proportion of patients with HbA1c measurements
Time Frame: 12 months
Proportion of patients with any HbA1c measurements in the 12-months period surrounding acute hemorrhagic stroke (6-months before and 6-months follow-up following discharge). HbA1c measurements will be ascertained based on electronic health record documentation.
Secondary Outcomes
- Proportion of patients with management of obstructive sleep apnea(6-months)
- Proportion of patients with management of hearing impairment(6-months)
- Proportion of patients with intensification of lipid-lowering therapy(6-months)
- Proportion of patients with intensification of antidiabetic therapy(6-months)